Related Experiment Videos
Vasopressin receptors in health and disease
1Department of Medicine, Université de Montréal, Hôpital du Sacré-Coeur de Montréal, Québec, Canada.
Abstract:
The molecular cloning and characterization of receptors for the nonapeptide hormone family vasopressin-oxytocin was rapidly followed by the identification of mutations in the V2 receptor gene segregating with the clinical phenotype in more than a hundred families with X-linked nephrogenic diabetes insipidus. Together with the recent cloning of the vasopressin-regulated water channel in the apical membrane of the collecting duct tubule and of the identification of rare autosomal recessive nephrogenic diabetes insipidus patients with mutations in the AQP2 gene, these developments enable carrier detection and early diagnosis of infants with congenital nephrogenic diabetes insipidus.
Insights
Genetic mutations in the V2 receptor and AQP2 genes cause nephrogenic diabetes insipidus. Identifying these mutations allows for early diagnosis and carrier detection in affected families.
Area of Science:
- Endocrinology and genetics
- Molecular biology and nephrology
Background:
- Nephrogenic diabetes insipidus (NDI) is a disorder characterized by the kidneys' inability to respond to vasopressin.
- X-linked NDI is primarily caused by mutations in the V2 receptor gene, while rare autosomal recessive NDI is linked to AQP2 gene mutations.
Purpose of the Study:
- To investigate the genetic basis of nephrogenic diabetes insipidus.
- To establish methods for carrier detection and early diagnosis of congenital NDI.
Main Methods:
- Molecular cloning and characterization of vasopressin-oxytocin receptors.
- Genetic analysis of V2 receptor and AQP2 genes in NDI patients and families.
Main Results:
- Over a hundred families with X-linked NDI showed mutations in the V2 receptor gene.
- Rare autosomal recessive NDI cases were identified with mutations in the AQP2 gene.
Conclusions:
- Genetic defects in V2 receptor and AQP2 are key causes of NDI.
- These genetic findings facilitate carrier detection and early diagnosis of congenital NDI, improving patient management.